Boltz releases open-source molecular model
The story so far
Boltz releases open-source molecular model, allowing scientists to predict molecular interactions based on drug properties, generate specified molecules, and optimize designs. Its model has been adopted by 20 top pharmaceutical companies globally, with weekly molecular token consumption increasing by about 50 times in 4 months, and supports fine-tuning the model on proprietary data from companies like Pfizer.
AI-written from the reports · Updated 6 hours ago
Coverage timeline
Follow the coverage to see every side of the story.
- a16z NewsInvesting in Boltz
Boltz releases open-source molecular model, allowing scientists to predict molecular interactions based on drug properties, generate specified molecules, and optimize designs. Its model has been adopted by 20 top pharmaceutical companies globally, with weekly molecular token consumption increasing by about 50 times in 4 months, and supports fine-tuning the model on proprietary data from companies like Pfizer.
Heat over time
- Now
- 8
- Peak
- 1019 Nov, 00:00
- 24h change
- –
Hover or tap the chart to see each hour; use the arrow keys on a keyboard.